Patients with ovarian cancer (total group) had statistically considerably higher levels of researched factors (VEGF p = 0.0011; HE4 p < 0.001; CA125 p < 0.001) than those observed in benign ovarian tumor patients (Table 2). Here, VEGFA is linked to ovarian carcinoma.